Ignite Creation Date:
2024-05-06 @ 1:08 AM
Last Modification Date:
2024-10-26 @ 11:00 AM
Study NCT ID:
NCT01743898
Status:
COMPLETED
Last Update Posted:
2014-08-04
First Post:
2012-10-07
Brief Title:
A Prospective Pharmacodynamic Study of Rivaroxaban
Sponsor:
Organization:
University of North Carolina Chapel Hill
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
65
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 19989 |
Who Masked List: